The public comment period ends February 3. Public comments can be made in-person, online, by call or by email.
University of Kentucky HealthCare plans to put an outpatient treatment center on property it owns in Hamburg, hospital ...
NervGen Pharma Corp. ("NervGen" or the "Company") (TSXV: NGEN) (NASDAQ: NGEN), a clinical-stage biopharmaceutical company developing first-in-class ...
NervGen Pharma Corp. ('NervGen” or the 'Company') (TSXV: NGEN) (NASDAQ: NGEN), a clinical-stage biopharmaceutical company developing first-in-class neuroreparative therapeutics for spinal cord injury ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback